ATE44460T1 - Arzneimittelueberzug. - Google Patents

Arzneimittelueberzug.

Info

Publication number
ATE44460T1
ATE44460T1 AT85101097T AT85101097T ATE44460T1 AT E44460 T1 ATE44460 T1 AT E44460T1 AT 85101097 T AT85101097 T AT 85101097T AT 85101097 T AT85101097 T AT 85101097T AT E44460 T1 ATE44460 T1 AT E44460T1
Authority
AT
Austria
Prior art keywords
dosage forms
pharmaceutical dosage
polymer
coating
resistant
Prior art date
Application number
AT85101097T
Other languages
German (de)
English (en)
Inventor
Klaus Dr Lehmann
Dieter Dreher
Harry Goetz
Original Assignee
Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Gmbh filed Critical Roehm Gmbh
Application granted granted Critical
Publication of ATE44460T1 publication Critical patent/ATE44460T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04—Homopolymers or copolymers of esters
    • C09D133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09D133/062—Copolymers with monomers not covered by C09D133/06
    • C09D133/064—Copolymers with monomers not covered by C09D133/06 containing anhydride, COOH or COOM groups, with M being metal or onium-cation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04—Homopolymers or copolymers of esters
    • C09D133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09D133/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/062—Copolymers with monomers not covered by C08L33/06
    • C08L33/064—Copolymers with monomers not covered by C08L33/06 containing anhydride, COOH or COOM groups, with M being metal or onium-cation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AT85101097T 1984-02-15 1985-02-02 Arzneimittelueberzug. ATE44460T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843405378 DE3405378A1 (de) 1984-02-15 1984-02-15 Arzneimittelueberzug
EP85101097A EP0152038B1 (de) 1984-02-15 1985-02-02 Arzneimittelüberzug

Publications (1)

Publication Number Publication Date
ATE44460T1 true ATE44460T1 (de) 1989-07-15

Family

ID=6227795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85101097T ATE44460T1 (de) 1984-02-15 1985-02-02 Arzneimittelueberzug.

Country Status (7)

Country Link
US (2) US4644031A (enExample)
EP (1) EP0152038B1 (enExample)
JP (1) JPS60190725A (enExample)
AT (1) ATE44460T1 (enExample)
DD (1) DD232646A5 (enExample)
DE (2) DE3405378A1 (enExample)
HU (1) HU203968B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3524337A1 (de) * 1985-07-08 1987-01-08 Roehm Gmbh Arzneimittelumhuellung
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
DE9015551U1 (de) * 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
JPH0720848Y2 (ja) * 1992-09-25 1995-05-15 日東工業株式会社 端子装置
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
IL142896A0 (en) * 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
CA2396237A1 (en) * 2000-01-07 2001-07-19 Jacob Gabriel Michael Selective activation of a th1 or th2 lymphocyte regulated immune response
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
CA2460132A1 (en) * 2001-10-15 2003-04-24 Roehm Gmbh & Co. Kg Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
DE60209673T2 (de) * 2002-10-22 2006-09-21 Rohm And Haas Co. Tablettenbeschichtung
CA2533178C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) * 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
CA2550983C (en) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
WO2006106815A1 (ja) * 2005-03-31 2006-10-12 Takeda Pharmaceutical Company Limited 錠剤
BRPI0608917A2 (pt) * 2005-04-12 2017-07-11 Elan Pharma Int Ltd Composição de liberação controlada de antibiótico, e, método para o tratamento de infecção bacteriana
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
EP2720682B1 (en) * 2011-06-17 2016-11-23 Evonik Röhm GmbH Coating composition suitable for pharmaceutical or nutraceutical dosage forms
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
EP3653203A4 (en) 2017-07-11 2020-06-24 Qualicaps Co., Ltd. ENTERAL HARD CAPSULE
KR20210022716A (ko) 2018-06-22 2021-03-03 쿠오리카프스 가부시키가이샤 장용성 경질 캡슐

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH476499A (de) * 1964-12-31 1969-08-15 Ciba Geigy Mischung zum Überziehen von Rektal-Kapseln
DE1617351A1 (enExample) * 1967-06-28 1972-01-05
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
BE785702A (fr) * 1971-07-14 1972-10-16 Roehm Gmbh Produits de revetement de formes medicamenteuses et leur utilisation
DE2135073C3 (de) * 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
DE3049179A1 (de) * 1975-03-20 1982-07-29 Röhm GmbH, 6100 Darmstadt Bindemittel fuer arzneimittelueberzuege.
DE2966893D1 (en) * 1978-10-02 1984-05-17 Purdue Research Foundation Foods and pharmaceutical coating composition, method of preparation and products so coated
DE3034949A1 (de) * 1980-09-17 1982-05-06 Hoechst Ag, 6000 Frankfurt Waessrige kunststoffdispersion, verfahren zu ihrer herstellung, ihre anwendung und aus der kunststoffdispersion hergestellte folie
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3106449A1 (de) * 1981-02-20 1982-09-09 Röhm GmbH, 6100 Darmstadt "in magensaft loesliche oder quellbare ueberzugsmasse und ihre verwendung in einem verfahren zum ueberziehen von arzneiformen"
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
JPS5815567A (ja) * 1981-07-21 1983-01-28 Nippon Paint Co Ltd 水性塗料組成物
DE3134222A1 (de) * 1981-08-29 1983-03-10 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung von acrylkunststoffdispersionen
JPS5859266A (ja) * 1981-10-05 1983-04-08 Nippon Paint Co Ltd 水性塗料組成物
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4504609A (en) * 1982-10-04 1985-03-12 Nippon Paint Co., Ltd. Aqueous coating composition

Also Published As

Publication number Publication date
EP0152038A2 (de) 1985-08-21
US4644031A (en) 1987-02-17
HU203968B (en) 1991-11-28
DE3405378A1 (de) 1985-08-22
DD232646A5 (de) 1986-02-05
EP0152038B1 (de) 1989-07-12
USRE35200E (en) 1996-04-02
HUT38664A (en) 1986-06-30
DE3571393D1 (en) 1989-08-17
EP0152038A3 (en) 1987-04-22
JPH0572369B2 (enExample) 1993-10-12
JPS60190725A (ja) 1985-09-28

Similar Documents

Publication Publication Date Title
DE3571393D1 (en) Coating for pharmaceutical compositions
AU570712B2 (en) Crosslinked, porous polymers for controlled drug delivery
DK0391342T3 (da) Spraygelbasis og spraygel, fremstilling og anvendelse deraf
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
HK48392A (en) Drug particles having constant release and immediate release
KR890009376A (ko) 분무 건조된 이부프로펜
DK400685A (da) Praeparat med kontrolleret afgivelse
KR870000069A (ko) 안정한 고체 제형의 제조 방법
IE811911L (en) Suspension-yielding powder
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
DK0454383T3 (da) Oral formulering med polypeptidserie til dissociering i tyktarmen
FR2663207B1 (fr) Procede d'enrobage par un polymere ph sensible de principes actifs.
AU590585B2 (en) Pharmaceutical coating
EP0083835A3 (en) Stabilization of diazo-resin sensitisers
EP0374796A3 (en) Stable emulsion formulations of water-insoluble organic pesticides, their use and preparation
CA2126200A1 (en) Prolamine Coatings for Taste-Masking Orally-Administrable Medicaments
MX9205579A (es) El recubrimiento de formas de droga
SE8902699D0 (sv) Diltiazem containing pharmaceutical compositios
KR910004179A (ko) 아스피린 과립 및 빠른-개시 투여 형태
EP0190996A3 (en) Crosslinked, porous polymers for controlled delivery of agricultural ingredients
JPS56139413A (en) Analgesic embrocation for lumbago and muscular pain
FR2216989A2 (en) Granules contg petroleum jelly - laxatives
GB1284438A (en) Pharmaceutical tablet
JPS52148625A (en) Aqueous dispersion of pesticides

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time